State Tele-Buprenorphine Policies for Medicaid, August 2025

August 2025 snapshot of state-level statutes, administrative regulations, and Medicaid reimbursement policies relevant to fully virtual telemedicine prescribing of buprenorphine. The dataset was authored by Jessica Sousa and published on Harvard Dataverse, with a last update recorded on April 14, 2026.

Use Cases

• Compare state-level regulatory frameworks for telemedicine prescribing based on the described policy categories.
• Analyze Medicaid reimbursement policies for virtual buprenorphine care across different states.
• Map the legal landscape for different provider types (MDs, NPs, PAs) delivering tele-buprenorphine.
• Identify policy gaps or variations affecting access to medication-assisted treatment via telehealth.

Strengths

• Focuses on a specific and timely policy area (tele-buprenorphine for Medicaid) as of a defined date.
• Covers three distinct policy dimensions: statutes, regulations, and reimbursement, as described.
• Includes policies for three provider types (MDs, NPs, PAs), providing comparative detail.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

Harvard Dataverse

Collection Method

Summarization of state statutes, administrative regulations, and Medicaid policies.

Time Range

Snapshot as of August 2025

Freshness

Last updated 2026-04-14 20:17:04; freshness should be verified.

Geography

United States (state-level)